The German fibromyalgia consumer reports - a cross-sectional survey
- PMID: 22607517
- PMCID: PMC3444387
- DOI: 10.1186/1471-2474-13-74
The German fibromyalgia consumer reports - a cross-sectional survey
Abstract
Background: Consumer surveys provide information on effectiveness and side effects of medical interventions in routine clinical care. A report of fibromyalgia syndrome (FMS) consumers has not been carried out in Europe.
Methods: The study was carried out from November 2010 to April 2011. Participants diagnosed with FMS rated the effectiveness and side effects of pharmacological and non-pharmacological FMS interventions on a 0 to 10 scale, with 10 being most efficacious (harmful). The questionnaire was distributed by the German League for people with Arthritis and Rheumatism and the German Fibromyalgia Association to their members and to all consecutive FMS patients of nine clinical centers of different levels of care.
Results: 1661 questionnaires (95% women, mean age 54 years, mean duration since FMS diagnosis 6.8 years) were analysed. The most frequently used therapies were self-management strategies, prescription pain medication and aerobic exercise. The highest average effectiveness was attributed to whole body and local warmth therapies, thermal bathes, FMS education and resting. The highest average side effects were attributed to strong opioids, local cold therapy, gamma-amino-butyric acid analogues (pregabalin and gabapentin), tramadol and opioid transdermal systems.
Conclusion: The German fibromyalgia consumer reports highlight the importance of non-pharmcological therapies in the long-term management of FMS, and challenges the strong recommendations for drug therapies given by FMS-guidelines.
Similar articles
-
[German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies].Schmerz. 2012 Apr;26(2):150-9. doi: 10.1007/s00482-012-1161-5. Schmerz. 2012. PMID: 22527644 German.
-
[Are members of fibromyalgia syndrome self-help groups "different"? Demographic and clinical characteristics of members and non-members of fibromyalgia syndrome self-help groups].Z Rheumatol. 2013 Jun;72(5):474-81. doi: 10.1007/s00393-012-1119-0. Z Rheumatol. 2013. PMID: 23579856 German.
-
[Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].Schmerz. 2011 Aug;25(4):402-4, 406-10. doi: 10.1007/s00482-011-1079-3. Schmerz. 2011. PMID: 21818719 German.
-
[Physiotherapy, exercise and strength training and physical therapies in the treatment of fibromyalgia syndrome].Schmerz. 2008 Jun;22(3):303-12. doi: 10.1007/s00482-008-0675-3. Schmerz. 2008. PMID: 18449569 German.
-
Generalised and regional soft tissue pain syndromes. The role of physical and rehabilitation medicine physicians. The European perspective based on the best evidence. A paper by the UEMS-PRM Section Professional Practice Committee.Eur J Phys Rehabil Med. 2013 Aug;49(4):535-49. Eur J Phys Rehabil Med. 2013. PMID: 24084413 Review.
Cited by
-
Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin.Arthritis Care Res (Hoboken). 2013 Nov;65(11):1813-9. doi: 10.1002/acr.22071. Arthritis Care Res (Hoboken). 2013. PMID: 23861291 Free PMC article.
-
Investigating the Influential Factors of Mild Water-Filtered Infrared-A Whole-Body Hyperthermia for Pain Relief in Fibromyalgia: A Mixed-Methods Approach Focusing on Predictors and Patient Perspectives.Biomedicines. 2023 Nov 1;11(11):2949. doi: 10.3390/biomedicines11112949. Biomedicines. 2023. PMID: 38001951 Free PMC article.
-
Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies.Evid Based Complement Alternat Med. 2013;2013:485272. doi: 10.1155/2013/485272. Epub 2013 Nov 21. Evid Based Complement Alternat Med. 2013. PMID: 24348701 Free PMC article. Review.
-
Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults.Cochrane Database Syst Rev. 2017 Jul 12;7(7):CD012638. doi: 10.1002/14651858.CD012638.pub2. Cochrane Database Syst Rev. 2017. PMID: 28700091 Free PMC article.
-
Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia.Am Health Drug Benefits. 2018 Sep;11(6):293-301. Am Health Drug Benefits. 2018. PMID: 30464796 Free PMC article.
References
-
- Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62(5):600–10. doi: 10.1002/acr.20140. - DOI - PubMed
-
- Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubère JP, Le Lay K, Taieb C, Matucci-Cerinic M. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448–53. doi: 10.1016/j.semarthrit.2008.12.003. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous